Processa Pharmaceuticals, Inc. Share Price
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 21/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 2.145 USD | -0.23% |
|
-14.20% | -25.52% |
| Market Cap | 58.99L 50.51L 47.13L 43.24L 81.25L 56Cr 82.85L 5.59Cr 2.18Cr 28Cr 2.22Cr 2.17Cr 94Cr | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 4L 3L 3L 3L 5L 3.47Cr 5L 34.32L 13.38L 1.74Cr 13.6L 13.3L 5.75Cr | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | -0.23% | ||
| 1 week | -14.20% | ||
| Current month | -0.23% | ||
| 1 month | -3.38% | ||
| 3 months | -17.82% | ||
| 6 months | +2.14% | ||
| Current year | -25.52% |
| 1 week | 2.04 |  | 2.43 |
| 1 month | 1.8 | | 3.11 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 1,25,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 08/08/26 | Fiscal year | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/07/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/07/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -14.20% | -58.55% | -98.86% | 58.99L | |
| +2.38% | +3.43% | +82.88% | +115.89% | 7.4TCr | |
| -0.47% | +20.65% | +52.95% | +93.16% | 6.47TCr | |
| -4.27% | -0.99% | -3.38% | +475.61% | 2.73TCr | |
| -1.97% | +20.38% | -0.37% | +0.48% | 2.79TCr | |
| +2.74% | +12.98% | +62.84% | +28.14% | 2.6TCr | |
| -0.33% | +5.28% | +35.58% | -14.47% | 2TCr | |
| -1.79% | -4.84% | +239.54% | +414.48% | 1.78TCr | |
| +0.94% | +3.36% | +18.55% | +532.94% | 1.62TCr | |
| -1.29% | +6.09% | +41.81% | +154.45% | 1.33TCr | |
| Average | -0.43% | +4.15% | +47.19% | +170.18% | 2.87TCr | |
| Weighted average by Cap. | +0.02% | +8.21% | +58.94% | +160.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.19Cr -1.01Cr -94.66L -86.86L -1.63Cr -113.39Cr -1.66Cr -11Cr -4.38Cr -57Cr -4.45Cr -4.35Cr -188.13Cr | -1.36Cr -1.16Cr -1.08Cr -99.43L -1.87Cr -129.79Cr -1.91Cr -13Cr -5.01Cr -65Cr -5.09Cr -4.98Cr -215.34Cr |
| Net Debt | -11.18L -10L -9L -8L -15.4L -11Cr -15.7L -1.06Cr -41.3L -5.36Cr -41.97L -41.06L -18Cr | -55.37L -47.41L -44.23L -40.59L -76.27L -53Cr -77.77L -5.25Cr -2.05Cr -27Cr -2.08Cr -2.03Cr -88Cr |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | $2.145 | -0.23% | 27,537 |
| 19/26/19 | $2.150 | +2.38% | 25,072 |
| 18/26/18 | $2.100 | -1.41% | 51,877 |
| 17/26/17 | $2.130 | -12.35% | 61,305 |
| 14/26/14 | $2.430 | -2.80% | 50,194 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
